Zimmer Biomet (NYSE:ZBH) last week escalated its ongoing war with erstwhile partner Heraeus, filing a complaint with the U.S. International Trade Commission seeking to bar the German company from importing its bone cement products.
The ITC is already running an investigation into Zimmer’s bone cement imports at the behest of Heraeus. It’s all part of a bitter dispute in which each side accuses the other of pilfering trade secrets and poaching talent.